Literature DB >> 22108724

Pressure overload.

Edward D Frohlich1, Dinko Susic.   

Abstract

This review discusses cardiac consequences of pressure overload. In response to elevated pressure, the ventricular hypertrophy compensates for the increased wall stress. However, the ventricular hypertrophy involves numerous structural adaptations that may lead to ventricular dysfunction and, eventually, heart failure. Particular emphasis is placed on molecular mechanisms that govern the development of hypertrophy and that may lead to maladaptive structural changes resulting in adverse cardiac events. 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22108724     DOI: 10.1016/j.hfc.2011.08.005

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  16 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

2.  Chronic Ethanol Administration Prevents Compensatory Cardiac Hypertrophy in Pressure Overload.

Authors:  Van K Ninh; Elia C El Hajj; Alan J Mouton; Milad C El Hajj; Nicholas W Gilpin; Jason D Gardner
Journal:  Alcohol Clin Exp Res       Date:  2018-05-30       Impact factor: 3.455

Review 3.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 4.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

5.  Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling.

Authors:  Courtney Cates; Thomas Rousselle; Jinli Wang; Nanhu Quan; Lin Wang; Xu Chen; Likui Yang; Alireza R Rezaie; Ji Li
Journal:  Biochem Biophys Res Commun       Date:  2017-12-27       Impact factor: 3.575

6.  Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.

Authors:  Laura Benschop; Sarah Schalekamp-Timmermans; Zoe A Broere-Brown; Jeanine E Roeters van Lennep; Vincent W V Jaddoe; Jolien W Roos-Hesselink; M Kamran Ikram; Eric A P Steegers; James M Roberts; Robin E Gandley
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

Review 7.  Myocardial remodeling in hypertension.

Authors:  W Nadruz
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

Review 8.  Growth differentiation factor 15 in heart failure: an update.

Authors:  Kai C Wollert; Tibor Kempf
Journal:  Curr Heart Fail Rep       Date:  2012-12

9.  Transient ACE (Angiotensin-Converting Enzyme) Inhibition Suppresses Future Fibrogenic Capacity and Heterogeneity of Cardiac Fibroblast Subpopulations.

Authors:  Alexandra M Garvin; Matthew D De Both; Joshua S Talboom; Merry L Lindsey; Matthew J Huentelman; Taben M Hale
Journal:  Hypertension       Date:  2021-01-25       Impact factor: 10.190

10.  Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.

Authors:  Navid Koleini; Barbara E Nickel; Raghu S Nagalingam; Natalie M Landry; Robert R Fandrich; David Y C Cheung; Ian M Dixon; Michael P Czubryt; Davinder S Jassal; Peter A Cattini; Elissavet Kardami
Journal:  Cell Tissue Res       Date:  2021-05-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.